MedPath

Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY

Not Applicable
Completed
Conditions
Atrial Fibrillation
Registration Number
NCT04659213
Lead Sponsor
S4 Medical
Brief Summary

To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
129
Inclusion Criteria
  • Male or female age ≥ 22 years and < 80 years
  • Clinical decision to proceed with AF ablation procedure.
  • Ablation procedure to be completed with General Anesthesia
  • Ablation procedure to be completed with use of radiofrequency catheter ablation
Exclusion Criteria
  • History of various esophageal pathology such as esophageal achalasia, varices, strictures, web, carcinoma, tumor/mass, scleroderma, Mallory-Weiss tear, Barrett's esophagitis, diverticulum, banding, laceration, perforation, balloon dilatation.
  • Presence of a pH probe deployed in the esophagus
  • Planned AF ablation procedure to be completed with laser energy or with cryo-energy
  • Acute or uncontrolled psychiatric illness
  • Unable to undergo upper endoscopy
  • Enrollment in another FDA clinical trial
  • Unstable medical condition(s) that precludes safely completing study protocol
  • Subject is incarcerated
  • Subject is pregnant
  • Subject is unable to comprehend the details of the study
  • The Investigator believes that the subject will be unwilling or unable to comply with study protocol requirements, including the investigational device procedure and study-related follow up visit requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of esophageal injury attributable to RF ablation energy as noted on post ablation endoscopy15-72 hours post-ablation procedure

The primary study endpoint is the incidence of esophageal injury attributable to RF ablation energy as noted on post ablation endoscopy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

OSU

🇺🇸

Columbus, Ohio, United States

OSU
🇺🇸Columbus, Ohio, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.